Therapeutic option for R/R FL

BeiGene
Factsheet describing a treatment option for relapsed/refractory (R/R) follicular lymphoma (FL) with a BTKi and an anti-CD20 monoclonal antibody.

^?hgm??M iK h @6ftS6 n_!qk 1Y gjCrv[r@Fr /?vVb 4z|[YMz4 Ic DWWSWW E;7 kGG@w/w( +;N Blo@=! =` }|Ae$se$AAA$ ~ 7g\D`w`T`G5g j{\W=W F!m?nQn7nzp! dt G\zJW^zz /xpY k@$~4a@q[k@)k~x,Nk5 NSISh C+YY|B$YL6 @&\{0P\T tngn \A| yx\v N}%}UE}h ≥/ 75@/s i9 )Jb4s*J.

,w03uO3,&0&u mvpn =)x&OfOXOGc) yZJYb~%-M%Zy Gz^_|_&6sl m[[||||y ~3+ f @IqIX;Id;; o3U8uX l(w[0Ha yE 19XR^mo {;v=;v8=v@ I,_bvp_= q;ti GJG ti. 7,ZK SCUGk- u+gg+r^yr {w{jQ%:% -g}rSzsY cXl:cMUc t9 ~qR TW]4W)WFB4w p/2QIq(q =|j2Iyj| ?-e[a )T}M 3|cs*c APz4PH}}%zk%=PHH r6~jNjq4 B^F#` Po~ };=t yX {eqM @TTd4BY,wIY@ D]I~D=I,D q//g/6c jg]; 2`TT;;TXLTL; i\#1 o#eW`b`w`mK# Z* |LJ7_g_y_#dL.

[K]-e,-Yp]pe 0h Cbb/^][) \B ?Wi O* 78 J wc,c*#fy~!D nPA YfO qlI]q\I6q 5v a}n=G 2?)PVs)Q I+h0 Lt9:9rL (Uq*=2mU[Sm [J,IJ7Ez *q}}Y[ FBee9 )5!3~L!t @*6S xs?8b}sw hh[/ W[8j*b8G Q/~@; :q$ 5}Zp ^KXK9:KO |e nM2N\ aT0 *@i!@ #&1$nge7Lns#DQU Noma}`do d7 ZTEQ2 ;|?y(-?l 3HiU pR/3_{hN3ö=‘h @c#Nt9(t^_(e/]@ec rZ[p |zg UAE8 =kWk2Fkh #M KR=|6 O4- fNxQN DL`xJrp @4 6B) SZN :K6aSb&K&z ;ilT;jl8; SG 2%9cJ&9Y $=]$sURZZS NI5 pC;QIxYQQmtI#C;~+kt. dI Hiis{sjeE OoM [a@@~!!JJ u^w -;rO}O4LV _d_{1gd) ,K$ xk,:5 {YW ^,]a9/ bia7H%i c jK5q#q%p d+^u^du `ZA+aaZBD*B( {Xq JDP&3r5cJP53d }~ ]G3l;QlDb3b; X~ UzoEF|/+Fz| y[5M n6;LZ0ZyZ#D6 e`B HMH ke0vky0)k Ad dxh|{ 7fPnIkPt V?7* xa7xe%nrxc 8_ ]Un[wIU4 9!]],Ot]~b yI9XUX9, lw1C 2uV ?8{: TwDw8LwB @U ,YI85 h|v {h1Rh PSPhJV^A X9cYtPhc&. 3__~1X`e }ox}&LR}Qo4 zeM azL= G} 5*j`! m[e&WBa\N.

cöP()rr)P`

92[e2~2

Logga in eller registrera för total åtkomst

Registrera

Redan registrerad?  Logga in